View Author
patient psoriasis treatment therapy study dermatol evidence disease ciclosporin guideline response effect dermatology table plaque psoriasis methotrexate infection grade european combination infliximab group psoriasis vulgaris efficacy pasi 75 response phototherapy efalizumab vulgari plaque result author reaction adalimumab improvement etanercept level 12 weeks suppl trial liver jeadv quality academy venereology induction journal increase compilation 5–70 venereology guidelines pregnancy symptom maintenance side effects pasi /bsa arthritis venereology pathirana regimen arthritis acitretin interaction malignancy measure © 2009 contraindication retinoid serum safety consensus assessment reduction psoriasis patients finition 5 mg /kg randomized blood alefacept erythema exposure induction therapy pasi 75
2 Most Recent Publications
|
Definition of treatment goals for moderate to severe psoriasis: A European consensus
(Article)
Mrowietz, U. Kragballe, K. Bylaite, M. Correia, O. Daudén, E. Gisondi, P. Iversen, L. Kemény, L. Lahfa, M. Nijsten, T.E.C. Rantanen, T. Reich, A. Reich, K. Rosenbach, T. Segaert, S. Smith, C. Talme, T. Volc-Platzer, B. Yawalkar, N. Spuls, P. Griffiths, C.E.M. Nast, A. Franke, J. Antoniou, A.C. Arenberger, P. Balieva, F. |
2011-01-01
|
|
European S3-guidelines on the systemic treatment of psoriasis vulgaris
(Article)
Pathirana, D. Ormerod, A.D. Dubertret, L. Eberlein, B. Erdmann, R. Ferguson, J. Girolomoni, G. Gisondi, P. Giunta, A. Griffiths, C.E.M. Hönigsmann, H. Hussain, M. Saiag, P. Jobling, R. Karvonen, S.L. Kemeny, L. Kopp, I. Leonardi, C. MacCarone, M. Menter, A. Mrowietz, U. Naldi, L. Nijsten, T.E.C. Smith, C. Ortonne, J.P. Orzechowski, H.D. Rantanen, T. Reich, K. Reytan, N. Richards, H. Thio, H.B. Kerkhof, P.C.M. van de Rzany, B. Spuls, P.I. Nast, A. Barker, J. Bos, J.D. Burmester, G.R. Chimenti, S. |
2009-10-01
|
